je.st
news
Isis Pharmaceuticals forms Cambridge subsidiary, plans to hire 20
2015-01-06 19:20:39| Biotech - Topix.net
California biotech Isis Pharmaceuticals , known for its drugs for rare and cardiovascular diseases using RNA-based technology, is forming a Cambridge subsidiary to further development of its drugs to control fat and cholesterol in the blood. Akcea Therapeutics is being called the "lipid franchise" of Carlsbad, Calif.-based Isis in a statement today, to be headed by former Genzyme Corp. and Moderna Therapeutics executive Paula Soteropoulos .
Tags: plans
forms
hire
cambridge
Category:Biotechnology and Pharmaceuticals